Switzerland-based pharma solutions provider Linnea is targeting cosmetics and personal care thanks to new delivery technology that brings its botanical extracts to the skin care category for the first time.
This week, Emulate announced new funding and research partnerships that will advance the technology, which has significant potential for cosmetic and personal care development and testing.
Health Canada is set to launch consultations this fall on a new framework aimed at streamlining and updating the current regulations for cosmetics that are currently defined as “drugs” under the Food and Drugs Act.
Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
US-based biotech company Divine Skin (DS) has partnered with Indian manufacturer Ranbaxy Laboratories, as it looks to offer hair growth treatments and take advantage of the pharmaceutical firm's distribution channels.
Johnson & Johnson said sales for its US consumer products division were hard hit by a series of recalls during the period, but other divisions helped to boost the group result.
A bimatoprost-containing eyelash product can enhance lash growth when used for six months but the treatment is not without side effects, according to recent research.
Skinvisible has signed a partnership with RHEI Pharmaceuticals of Belgium, allowing it to license its dermatology products in China, Hong Kong and Taiwan.
Pharmaceutical developer Skinvisible and active ingredients specialist Cambrex have joined forces with the aim of bringing new acne treatments to market.
Eyelash enhancers have blurred the line between cosmetics and drugs
landing two companies in a regulatory snare but La Canada Ventures
has been careful to avoid trouble.
A US company's eyelash lengthening product is currently under
investigation by the Medicines and Healthcare products Regulatory
Agency (MHRA) in the UK following its removal from the US market.
Regulators seized about $2m worth of an eyelash lengthening
product, one of a new breed of beauty goods that fall into
regulatory no-man's land between drugs and cosmetics.
A new trend more commonly linked to the pharmaceutical industry is
emerging within cosmetics - with many consumers now using
transdermal drug delivery patches to help fight body issues such as
cellulite and eye contour wrinkles.
Massachusetts-based Covaris Process says that the global cosmetic
industry will soon be able to benefit from acoustic technology
developed for ultra-fine compounds, nano particles, colloid and
micro emulsion formulation within pharmaceutical...
New Jersey-based IGI, a developer of technologies for skin care
applications, is making clear moves in preparation for a takeover,
after the company's financial representatives stated that some of
its past clients may be interested...
A US cosmetics company says it will try to further a technology it
has developed for skin care products in an attempt to break into
the drug delivery for cancer prevention treatments and gene repair
agents.
Preliminary studies find that a nanotech drug delivery system has
been developed to increase the efficacy of a prescription tanning
agent for fair-skinned people, reports Phil Taylor and Simon
Pitman.
Does the pharmaceutical industry's future lie at the boundary
between drugs and cosmetics? Or is the prospect of effective
'cosmeceuticals' a beauty myth? Writing in the 29 August issue of
'Nature' Helen Pearson...
